Bull case
Nano X Imaging is supported by a gradually improving commercial trajectory, with fourth-quarter 2025 revenue rising to $3.7M from $3.0M on the back of teleradiology growth and Nanox Health IT, while management reaffirmed a $35M full-year 2026 revenue target that signals confidence in scaling adoption. The company’s positive outlook is further strengthened by its capital-light go-to-market strategy, using established regional partners like Digital X-Ray Imaging to accelerate Nanox.ARC deployments across major health systems in Arkansas, leverage entrenched service infrastructure, and reduce the operational friction that often slows medical imaging rollouts. Fundamentally, the thesis rests on Nanox.ARC’s positioning as a lower-cost, lower-radiation alternative to traditional CT, the expanding distribution cadence that should broaden access and utilization, and the company’s multi-segment platform in which Radiology Services already provides the key revenue base, even as the $17.5M non-cash impairment underscores that execution and reimbursement remain critical risks.